
Indian shares opened lower on Wednesday, with the S&P/BSE Sensex down 0.2%, following U.S. President Trump's announcement of a 50% tariff on copper imports and a hinted 200% tariff on pharmaceuticals, alongside reaffirming the August 1 tariff start date. This expansion of aggressive trade measures led to declines in major Indian stocks like Infosys and ICICI Bank, which fell around 1%, though pharma stocks such as Lupin and Biocon bucked the trend with gains around 2%.
Indian equity markets opened with modest declines, as evidenced by the S&P/BSE Sensex's 0.2% drop, driven by an escalation in U.S. trade protectionism. The primary catalysts were President Trump's confirmation of the August 1 tariff start date, the introduction of a 50% tariff on copper imports, and a proposed 200% tariff on pharmaceuticals. This news prompted a risk-off sentiment in key sectors, with bellwethers such as Infosys, ICICI Bank, and Tata Steel each falling approximately 1%. In contrast, the pharmaceutical sector bucked the trend, with Lupin and Biocon gaining around 2%, suggesting investors may be reacting to the specific nature of the hinted tariffs or seeking defensive positioning. The market also showed a flight to quality, with consumer staples like Hindustan Unilever and Asian Paints rising 1%. Company-specific news remained a key driver, highlighted by Union Bank of India's 4.5% tumble following its Q1 business update, demonstrating that corporate fundamentals are being scrutinized alongside macroeconomic headlines.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment